Melanoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{YD}}; {{SSK}} | {{CMG}} {{AE}} {{YD}}; {{SSK}} | ||
==Overview== | ==Overview== | ||
Chest positron emission tomography (PET) may be considered for diagnosis of metastatic lesions among patients who have been diagnosed with stage IV melanoma and for secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma.<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | Chest positron emission tomography (PET) may be considered for diagnosis of metastatic lesions among patients who have been diagnosed with stage IV melanoma and for secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years).<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | ||
==Positron Emission Tomography (PET)== | ==Positron Emission Tomography (PET)== | ||
There are no chest PET findings associated with melanoma. | There are no chest PET findings associated with melanoma. | ||
Revision as of 01:38, 22 August 2015
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Melanoma other imaging findings |
|
Risk calculators and risk factors for Melanoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
Chest positron emission tomography (PET) may be considered for diagnosis of metastatic lesions among patients who have been diagnosed with stage IV melanoma and for secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years).[1]
Positron Emission Tomography (PET)
There are no chest PET findings associated with melanoma.
- Chest imaging using PET may be considered for diagnosis of metastatic lesions in the following conditions:[1]
- For patients who have been diagnosed with stage IV melanoma
- For secondary prevention of melanoma among patients who were previously diagnosed with Stage IIB-IV melanoma (annually for 5 years)
References
- ↑ 1.0 1.1 Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.